TrialRheumatology (Oxford, England)2023

Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.